Compare Jasnita Telekomindo Tbk (JAST) vs Merck Tbk. (MERK) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Jasnita Telekomindo Tbk vs Merck Tbk. — how do they compare? Jasnita Telekomindo Tbk trades at Rp85 (market cap 93.1B, 13.56M 24h volume), while Merck Tbk. trades at Rp3,840 (market cap 1.7T, 37.6K 24h volume). The key difference: Merck Tbk. is far larger — about 18.3× Jasnita Telekomindo Tbk's market cap, and Jasnita Telekomindo Tbk is more actively traded (13.56M versus 37.6K). Which is the better fit depends on your goals.
| JAST | MERK | |
|---|---|---|
Market Cap | 93.1B | 1.7T |
Volume | 13.56M | 37.6K |
Lot | 135.58K | 376 |
Turnover | 1.17B | 144.47M |
Average Price | 86.37 | 3,842.23 |
Value | 1.17B | 144.47M |
Indicative Equilibrium Price | 85 | 3,840 |
Indicative Equilibrium Volume | 907 | 7 |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Jasnita Telekomindo Tbk
PT Jasnita Telekomindo Tbk ("Company") was established in January 25,1996 based on the Deed of Establishment No. 119 dated January 25, 1996 which made before Agus Madjid, S.H., Notary in Jakarta which was later amended by the Amendment Act Articles of Association No. 45 dated August 14, 1996 made before Susi Susilowaty Wisnu, S.H., Substitute Notary from Agus Madjid, S.H., Notary in Jakarta.
Read more on JAST →About Merck Tbk.
PT Merck Tbk (the Company) is domiciled in Indonesia and located at Jl. TB Simatupang No. 8, Pasar Rebo, East Jakarta, was established in framework of Law No. 1 of 1967 and Law No. 11 of 1970 on foreign capital investment by deed of notary public Eliza Pondaag, SH dated 14 October 1970 No. 29. PT Merck Indonesia is a member of the Merck International Group. The company produces pharmaceutical products with production facility in East Jakarta. It commenced its operation in 1974 in manufacturing medical products, such as Songobian and Neurobion.
Read more on MERK →
